Medical Clearance in Dentistry. When Dentists Need Physician Consultation Before Dental Treatment
Dentistry has inherited a peculiar ritual. A patient reports diabetes, Eliquis, a knee replacement, pregnancy, kidney disease, a remote stroke, or some other medical condition, and the office reaches for a form. The form asks another doctor to certify that the patient is medically cleared for dentistry. It feels cautious. It creates documentation. It may even feel like liability has been shared. But in many routine cases, it does not answer the question the dentist actually needs answered.
The better question is simpler. What medical fact do I need that I cannot determine myself, and could the answer change whether, when, where, or how I perform this treatment. If there is no meaningful answer, a generic clearance request may add delay without adding safety. If there is an answer, the right tool is not permission. It is targeted medical consultation. This discussion assumes routine U.S. outpatient dental care, including extractions, local anesthesia and, when relevant, office sedation. State dental board rules, anesthesia permits and institutional policies may impose additional requirements.
That distinction is now strongly supported by contemporary guidance. A July 2026 review in The Journal of the American Dental Association, Medical clearance considerations for medically complex adult patients, frames the decision around four variables, ASA physical status, disease stability, symptom severity, and the risk of the planned dental procedure. That approach is far more useful than a list of diagnoses that supposedly require clearance. A stable patient with controlled hypertension receiving a small composite is not the same clinical problem as the same patient undergoing multiple surgical extractions under deep sedation. The diagnosis is only one part of the encounter.
Much of the confusion comes from memorable disasters. One dentist remembers the patient who bled for days. Another remembers the patient who stopped an anticoagulant and suffered a stroke. Another reads about an anesthesia death and concludes that every medically complicated patient needs physician approval. These stories are powerful because they are vivid, not because they establish the base rate of risk. The opposite mistake also occurs, dentists who conclude that medical consultation is meaningless because the dentist remains responsible for treatment. Both positions miss the point. Consultation is valuable when another clinician has information that can materially change dental management. It is not valuable merely because a signature feels protective.
Anticoagulants are one of the clearest examples. The ADA and CHEST both emphasize that minor dental bleeding is usually manageable with local measures, while unnecessary interruption of antithrombotic therapy can expose patients to stroke, myocardial infarction, systemic embolism, valve thrombosis, or stent thrombosis. For the typical patient undergoing one or a few uncomplicated extractions, routinely stopping apixaban, Eliquis, is generally not recommended. The same broad principle applies to rivaroxaban, aspirin, clopidogrel, and other commonly used agents, although the details differ by drug, indication, renal function, and procedural bleeding risk.
The dentist therefore needs to stop thinking in terms of the vague phrase blood thinner. Aspirin, clopidogrel, ticagrelor, warfarin, and apixaban are not interchangeable. Counting drugs is equally misleading. The old office rule that one blood thinner is acceptable but two means referral is not evidence based. Minor oral surgery can often be performed without interrupting even dual antiplatelet therapy. What matters is the pharmacology, why the patient takes the drug, the bleeding risk of the planned procedure, and whether bleeding can be controlled locally.
Warfarin remains different because INR provides useful information. Evidence supports many uncomplicated extractions while warfarin remains therapeutic, commonly at an INR of 3.0 or below, with some professional guidance accepting uncomplicated extraction at higher therapeutic values. DOACs such as Eliquis do not have a comparable routine INR target. An INR is not an Eliquis level. For limited surgery in a typical patient, pressure, absorbable hemostatic materials, sutures, and antifibrinolytic measures such as tranexamic acid usually make more sense than creating systemic thrombotic risk merely to make the socket more convenient.
There are exceptions. Extensive surgery, significant kidney or liver impairment, thrombocytopenia, hematologic disease, active chemotherapy, an unusual bleeding history, or other factors may materially increase risk. If altering a DOAC is being considered, the prescriber should be involved. The useful question is not, is this patient cleared for extraction. It is, this patient takes apixaban 5 mg twice daily for atrial fibrillation, I am planning two uncomplicated extractions with local hemostatic measures, is there any unusual thromboembolic, renal, or medical factor that would change the usual plan. That is information a dentist can use.
Diabetes follows the same pattern. The ADA and the American Diabetes Association do not treat HbA1c as a magic dental stop sign. Well controlled diabetes can usually be managed conventionally. Poor control can increase infection risk, impair healing, and complicate surgery, but there is no universal rule that an HbA1c above a particular number automatically requires antibiotics, referral, or physician clearance. An HbA1c of 7.6 tells you something. It does not tell you everything.
The operatory questions are more practical. Has the patient eaten normally. What medications are being used. Is there recurrent hypoglycemia. Are glucose levels currently stable. Is there kidney disease, cardiovascular disease, neuropathy, or poor wound healing. Will the planned surgery interfere with eating. Will sedation require fasting. A patient with stable type 2 diabetes needing one extraction is very different from an insulin treated patient with renal disease undergoing 19 extractions. When fasting, postoperative nutrition, or medication adjustment becomes important, medical coordination becomes useful because the physician can help manage a specific metabolic problem.
Hypertension is even more straightforward. The ADA recommends no modification for routine dental care when blood pressure is below 160 over 100 mmHg. If a reading is at or above that level, repeat it. Persistent elevation can justify postponing elective treatment and arranging medical evaluation. Readings approaching or exceeding about 180 systolic or 110 diastolic deserve substantially more caution, particularly when symptoms such as chest pain, dyspnea, headache, visual changes, or neurologic findings are present. None of that supports faxing a clearance request merely because the patient takes lisinopril.
Pregnancy may be dentistry’s most overused clearance. The ADA and the American College of Obstetricians and Gynecologists agree that preventive, diagnostic, restorative, periodontal, endodontic, and necessary surgical care can be performed throughout pregnancy. Indicated dental radiographs and local anesthesia are considered safe. Extractions, root canals, and restorations should not be delayed solely because a patient is pregnant, especially when postponement allows pain or infection to worsen.
A high risk pregnancy, severe preeclampsia, uncontrolled gestational diabetes, an unusual medication question, or planned sedation is different. Those circumstances create an actual question for the obstetrician. Pregnancy itself does not. A blanket office rule requiring OB permission before taking a needed radiograph or treating an abscess can become a barrier to care rather than a safety measure.
Recent cardiovascular events deserve a much lower threshold for consultation. A remote, stable history of stroke or coronary disease is not equivalent to a stroke nine days ago or a coronary stent placed two weeks ago. Contemporary ACC and AHA guidance uses stepwise risk assessment and discourages unnecessary testing in stable low risk patients. It pays much greater attention to acute coronary syndromes, decompensated heart failure, unstable arrhythmias, recent stroke, recent stenting, and severe symptomatic valvular disease. For dentists, the implication is simple. Stability and timing matter more than the diagnosis written on the medical history.
Sedation changes the equation again. The same medically complex patient who presents little additional risk for a small restoration under local anesthesia may become a very different patient under moderate sedation, deep sedation, or general anesthesia. The ADA’s 2025 sedation guidelines make this progression explicit. ASA III and IV patients may require physician or specialist consultation for minimal sedation. They should receive consultation for moderate sedation. Significant ASA III and IV patients undergoing deep sedation or general anesthesia must have consultation.
But consultation does not replace the dentist’s own preanesthetic assessment. Obesity, obstructive sleep apnea, airway anatomy, oxygen saturation, BMI, blood pressure, respiratory status, medication use, and fasting status remain the dentist’s responsibility. That is the real lesson from high profile anesthesia cases. The answer is not to send every obese patient to a PCP for a rubber stamp. The answer is to perform the airway and medical evaluation required for the depth of anesthesia being delivered, and to recognize when the office, team, or patient is not appropriate for that level of care.
Kidney disease demonstrates why the severity of disease matters. Mild chronic kidney disease does not automatically change routine dentistry. End stage renal disease and hemodialysis can. Advanced renal disease may alter platelet function, anemia, cardiovascular risk, drug clearance, and analgesic or antibiotic dosing. Dialysis adds scheduling and anticoagulation issues. In these patients, useful consultation may include dialysis timing, heparin exposure, current renal function, anemia, relevant medications, and whether drug doses need adjustment. Asking a nephrologist to simply write cleared for extraction discards most of the information that could actually improve care.
Cancer therapy and transplantation are even stronger examples of legitimate collaboration. Active chemotherapy can cause neutropenia and thrombocytopenia. Stem cell and organ transplant patients may be profoundly immunosuppressed, particularly early after transplantation. Head and neck radiation can create lifelong tissue and bone risks. In these cases, current platelet count, absolute neutrophil count, chemotherapy schedule, transplant stability, immunosuppressive intensity, radiation field, and radiation dose can directly change dental timing and treatment. This is not defensive paperwork. It is multidisciplinary treatment planning.
Antiresorptive drugs show why medication indication matters as much as medication name. An osteoporosis patient taking oral bisphosphonates or receiving Prolia is not in the same risk category as a patient receiving high dose zoledronic acid or Xgeva for metastatic cancer. AAOMS estimates MRONJ risk in osteoporosis patients as very low, and for most patients receiving antiresorptives for nonmalignant disease the operative plan does not need to be changed automatically. Routine drug holidays are controversial, and stopping denosumab can produce rebound bone loss and vertebral fractures.
The better questions are, what drug, what dose, what indication, how long has the patient taken it, when was the last dose, what other MRONJ risk factors are present, and is anyone considering altering therapy. Oncology dose antiresorptives are different. MRONJ risk is substantially higher, preventive dental care before therapy becomes more important, and elective dentoalveolar surgery may be avoided when reasonable alternatives exist. Again, the diagnosis or drug name does not determine the answer by itself.
Prosthetic joints provide another example of old habits surviving beyond the evidence. The 2024 AAOS guideline and the ADA’s 2026 guidance agree that routine antibiotic prophylaxis for immunocompetent patients with uncomplicated hip or knee replacements generally does not reduce prosthetic joint infection risk. Routine dental clearance before every total joint replacement has also not been shown to reduce PJI. Patients with previous prosthetic joint complications, major immunocompromise, or unusual orthopedic risk deserve individualized discussion, but a ten year old uncomplicated knee replacement is not a reason to automatically fax the surgeon or prescribe amoxicillin.
The reverse problem occurs when medicine asks dentistry for dental clearance. Sometimes that request is legitimate. ACC and AHA valvular heart disease guidance includes dental examination before certain valve interventions to identify potential infection sources. Oncology and transplant teams may reasonably want active odontogenic infection identified and treated before profound immunosuppression. What the dentist should avoid is pretending to guarantee the safety of somebody else’s operation.
A more defensible report is factual and dated. The patient was examined on a specific date. Appropriate radiographs were obtained. Active odontogenic infection was or was not identified. Existing disease was treated or remains present. That tells the surgeon what the dentist actually knows. A statement that the patient is dentally cleared for open heart surgery implies a degree of certainty and medical judgment that dentistry cannot provide.
The same principle should shape medical consultations coming into the dental office. The physician is not there to decide whether you can perform a crown, extraction, or periodontal procedure. The physician can tell you whether heart failure is currently decompensated, whether a coronary stent was placed two weeks ago, whether the patient is entering the neutropenic phase of chemotherapy, whether renal function has deteriorated, whether insulin needs modification because the patient will be fasting, or whether interrupting denosumab would create significant skeletal risk. Those facts can change dentistry.
Malpractice carriers tend to be more conservative, and their warnings deserve attention. Claims involving anticoagulants, pulmonary disease, sedation, cardiac arrest, and seizures show what can happen when important medical information is missed. But malpractice claims are a disaster enriched sample. They can expose failure points, but they do not prove that every similar patient requires clearance. The practical lesson is to document thoughtful risk assessment and meaningful consultation when it is indicated, not to turn the medical history into an automatic fax machine.
There is also one important legal caveat. Clinical evidence, institutional policy, and law are not the same thing. State dental boards, anesthesia permits, hospital systems, surgery centers, and specific statutes can impose requirements beyond what a national guideline recommends. A dentist cannot ignore a legal consultation requirement because a journal article suggests the patient is clinically low risk. Before building an office protocol, know which rules come from evidence, which come from local policy, and which come from regulation.
The most useful office rule may be one sentence. Before requesting medical consultation, complete this thought. I need the physician to tell me blank because if the answer is blank, I will change blank about my dental treatment. If the sentence cannot be completed intelligently, reconsider whether the consultation is necessary.
That approach protects autonomy without encouraging recklessness. It also improves workflow. Every unnecessary clearance creates another handoff, another phone call, another opportunity for the patient to disappear between diagnosis and treatment. Fewer unnecessary clearances can mean fewer delayed emergencies, fewer abandoned treatment plans, less staff time chasing signatures, and less friction at case acceptance. At the same time, patients who truly need collaboration receive better questions, better documentation, and more deliberate treatment planning.
Dentists generally do not need permission from physicians to practice dentistry. They sometimes absolutely need information from physicians to practice dentistry safely. Knowing the difference is where clinical judgment begins.
Are we using medical consultation to answer a real clinical question, or merely to make ourselves feel safer?
Join the Conversation!